Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer
Timothy R. Rebbeck(University of Pennsylvania), Saundra S. Buys(University of Utah), Kunle Odunsi(University of Chicago), Banu Arun(The University of Texas Health Science Center at Houston), Harsh B. Pathak(University of Kansas Medical Center), Dezheng Huo(University of Chicago Medical Center), Wendy K. Chung(Oregon Health & Science University), Fei Wan(California University of Pennsylvania), Hans Ehrencrona(Lund University), Salina Chan(University of California, San Francisco), Zakaria Einbeigi(Sahlgrenska University Hospital), Eitan Friedman(University of Pennsylvania), Andrew K. Godwin(The University of Melbourne), Alice S. Whittemore(Cancer Registry of Norway), Antonis C. Antoniou(Weatherford College), Katja Harbst(Lund University), Nandita Mitra(University of Pennsylvania), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Robert L. Nussbaum(National Institutes of Health), Simon A. Gayther(The University of Texas Health Science Center at Houston), Eric A. Ross(Fox Chase Cancer Center), Douglas F. Easton(University of Cambridge), Esther M. John, Christine Walsh(Cedars-Sinai Medical Center), Olufunmilayo I. Olopade(University of Chicago), Raanan Berger(Tel Aviv University), Mary Beth Terry(Columbia University Irving Medical Center), Susan M. Domchek(University City Science Center), Alexander Miron(Harvard University), Joyce Seldon(UCLA Jonsson Comprehensive Cancer Center), Katherine L. Nathanson(Translational Therapeutics (United States)), Beatrice Melin(Umeå University), Beth Y. Karlan(University of California, Los Angeles), Patricia A. Ganz(Los Angeles County Department of Public Health), Karen H. Lu(The University of Texas MD Anderson Cancer Center), Yael Laitman(Sheba Medical Center), Lesley McGuffog(University of Cambridge), Mary B. Daly(Fox Chase Cancer Center), Jenny Lester(Cedars-Sinai Medical Center), Sue Healey(QIMR Berghofer Medical Research Institute), Johanna Rantala(Karolinska University Hospital), Niklas Loman(Lund University), Gillian Mitchell(Peter MacCallum Cancer Centre), David E. Goldgar(University of Utah), Marie Stenmark‐Askmalm(Linköping University), Olga M. Sinilnikova(Hospices Civils de Lyon), Anya Kushnir(Sheba Medical Center), Shani Paluch–Shimon(Hebrew University of Jerusalem), Jamal Zidan(Rebecca Sieff Hospital), Sylvie Mazoyer(Université Claude Bernard Lyon 1)
Cited by 507
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k